|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Heart, Lung, and Blood Institute (NHLBI) |
|---|---|
| Information provided by: | National Institutes of Health Clinical Center (CC) |
| ClinicalTrials.gov Identifier: | NCT00001313 |
Purpose
In this study researchers will admit and evaluate patients with known or suspected heart disease referred to the Cardiology Branch of the National Heart, Lung, and Blood Institute (NHLBI).
Patients participating in this study will undergo a general medical evaluation, including blood tests, urine, examination, chest x-ray and electrocardiogram (EKG). In addition, patients may be asked to have an echocardiogram (ultrasound scan of the heart) and to perform an exercise stress test.
These tests are designed to assess the types and causes of patient's heart diseases and to determine if they can participate in other, specific research studies.
| Condition |
|---|
|
Peripheral Artery Disease Coronary Disease Diabetes and Heart Failure Dilated Cardiomyopathy Heart Failure Renal Artery Stenosis Pulmonary Hypertension |
| Study Type: | Observational |
| Official Title: | Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol) |
| Study Start Date: | May 1992 |
| Estimated Study Completion Date: | January 2009 |
The principal mission of the NIH is the conduct of research that elucidates biological mechanisms, pathogenesis, and treatment of disease. Patients with known or suspected cardiovascular diseases are referred to NHLBI cardiologists for consideration of participation in clinical research protocols.
However, eligibility for participation is often uncertain from referral information or even after an outpatient evaluation. The purpose of this protocol is to permit inpatient evaluation of patients for whom participation in clinical research protocols is under consideration in order to determine protocol eligibility by means of conventional laboratory and cardiovascular testing.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
The following is a representative list of the types of patient presentations and potential diagnoses eligible for this protocol:
EXCLUSION CRITERIA:
Pregnancy, for those patients who require catheterization-based diagnostics.
Inability to provide informed consent.
Contacts and Locations| United States, Maryland | |
| Suburban Hospital | |
| Bethesda, Maryland, United States, 20814 | |
| National Institutes of Health Clinical Center, 9000 Rockville Pike | |
| Bethesda, Maryland, United States, 20892 | |
More Information
| Study ID Numbers: | 920189, 92-H-0189 |
| Study First Received: | November 3, 1999 |
| Last Updated: | January 7, 2009 |
| ClinicalTrials.gov Identifier: | NCT00001313 History of Changes |
| Health Authority: | United States: Federal Government |
|
Cardiac Diagnosis Chest Pain Hypertrophic Cardiomyopathy Coronary Artery Disease Microvascular Angina |
Cardiac Investigation Follow-up Heart Disease Chest Pain Coronary Artery Disease |
|
Dilated Cardiomyopathy Myocardial Ischemia Cardiomyopathy, Dilated Angina Pectoris Pain Constriction, Pathologic Renal Artery Obstruction Arteriosclerosis Urologic Diseases Respiratory Tract Diseases Cardiomyopathy, Hypertrophic Kidney Diseases Arterial Occlusive Diseases Heart Failure Heart Diseases |
Diabetes Mellitus Vascular Diseases Microvascular Angina Ischemia Cardiomyopathies Chest Pain Coronary Disease Hypertrophy Hypertension, Pulmonary Lung Diseases Renal Artery Stenosis Cardiomegaly Coronary Artery Disease Hypertension |
|
Arterial Occlusive Diseases Heart Failure Heart Diseases Myocardial Ischemia Cardiomyopathy, Dilated Vascular Diseases Arteriosclerosis Renal Artery Obstruction Cardiomyopathies Coronary Disease |
Urologic Diseases Respiratory Tract Diseases Hypertension, Pulmonary Lung Diseases Cardiovascular Diseases Kidney Diseases Cardiomegaly Coronary Artery Disease Hypertension |
